首頁 > 市場調查報告書 > 製藥

生物製劑

合成生物學市場規模、佔有率和成長分析（按工具、應用、技術和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1899865

合成生物學市場規模、佔有率和成長分析（按工具、應用、技術和地區分類）－2026-2033年產業預測

Synthetic Biology Market Size, Share, and Growth Analysis, By Tool (Oligonucleotides and Synthetic DNA, Enzymes), By Application (Medical Application, Pharmaceuticals), By Technology, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，合成生物學市場價值將達到 178 億美元，到 2025 年將成長至 223.4 億美元，到 2033 年將成長至 1374.7 億美元，在預測期（2026-2033 年）內複合年成長率為 25.5%。

在技術創新和對永續解決方案日益成長的需求的推動下，合成生物學市場預計將顯著擴張。 Cas9和CRISPR基因編輯技術以及合成基因合成等技術的快速發展，正在提高合成生物學應用的成本效益和實用性。環境問題和對永續性的迫切需求，促使人們更加關注開發環保解決方案，包括綠色化學品、可生物分解材料和生質燃料。然而，關於基因改造和生物安全的倫理問題和嚴格的法規結構，對商業化和研究舉措構成了挑戰。儘管存在這些障礙，先進治療方法和個人化醫療的出現，為變革醫療保健和解決以往無法治癒的疾病提供了巨大潛力，展現了其對產業的變革性影響。

全球合成生物學市場按工具、應用、技術和地區進行細分。依工具分類，可分為寡核苷酸和合成DNA、酵素、克隆技術試劑盒、合成細胞、底盤生物體和異源核酸。按應用分類，可分為醫療應用、製藥、藥物發現和治療、其他醫療應用、人工組織和組織再生、工業應用、其他行業、食品和農業以及環境應用。依技術分類，可分為基因合成、基因組工程、定序、生物資訊學、特異性誘變、克隆、測量和建模、微流體和奈米技術。按地區分類，可分為北美、歐洲、亞太、中東和非洲以及拉丁美洲。

合成生物學市場促進因素

合成生物學市場正經歷顯著成長，這主要得益於創新治療方法、診斷方法和疫苗研發的進步，這些技術在醫療保健和製藥行業的應用日益廣泛。此外，該技術在培育抗病蟲害能力更強的基因改造作物方面也發揮關鍵作用，有助於提高農業生產力並增強糧食安全。這些變革性的能力共同推動了對合成生物學解決方案日益成長的需求，最終促進了整個市場的擴張。隨著各行各業逐漸認知到其潛在優勢，合成生物學的影響範圍也不斷擴大，涵蓋了許多應用領域。

合成生物學市場限制因素

合成生物學市場面臨許多挑戰，其中技術研發的高昂初始成本限制了其擴充性和普及性。此外，合成生物學系統的設計、建構和整合過程的複雜性也構成了重大障礙，可能損害這些創新技術的整體可靠性和效率。企業在克服這些障礙的過程中，可能會遇到阻礙其發展和產業內廣泛應用的限制。因此，合成生物學相關的財務負擔和技術難題有可能抑制這一充滿前景卻又複雜的領域的成長和投資，從而限制其對各個行業的潛在影響。

合成生物學市場趨勢

隨著新興企業逐漸意識到基因表現、表觀遺傳學和DNA序列之間複雜交互作用所帶來的挑戰，合成生物學市場正呈現表觀遺傳技術創新的顯著趨勢。合成構建體過度活化導致的不一致性凸顯了基因工程領域對更精確、更可控方法的需求。新參與企業正在開發先進的解決方案，以更有效地操控表觀遺傳因子，從而提高合成生物學應用的可靠性和可預測性。這種對克服表觀遺傳學挑戰的關注有望推動包括農業、醫療保健和工業生物技術在內的多個領域的進步。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 義大利
- 法國
- 英國
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市集活動
主要企業市佔率（2025 年）

主要企業簡介

[if!supportLists][endif]Thermo Fisher Scientific, Inc.（US）
Merck KGaA（Germany）
Agilent Technologies（US）
Novozymes（Denmark）
Ginkgo Bioworks（US）
Amyris（US）
Precigen, Inc.（US）
GenScript（China）
Twist Bioscience（US）
Synthetic Genomics（US）
Codexis, Inc.（US）
Synthego（US）
Creative Enzymes（US）
Eurofins Scientific（Luxembourg）
Bota Biosciences Inc.（China）
Creative Biogene（US）
Enbiotix, Inc.（US）
Illumina, Inc.（US）
New England Biolabs（US）
Pareto Bio, Inc.（US）

簡介目錄

Product Code: SQMIG35H2209

Synthetic Biology Market size was valued at USD 17.8 Billion in 2024 and is poised to grow from USD 22.34 Billion in 2025 to USD 137.47 Billion by 2033, growing at a CAGR of 25.5% during the forecast period (2026-2033).

The synthetic biology market is poised for substantial expansion driven by innovations and an increasing demand for sustainable solutions. Rapid advancements in technologies such as Cas9 and CRISPR gene editing, alongside synthetic gene synthesis, enhance the cost-effectiveness and practicality of synthetic biology applications. Heightened interest in creating eco-friendly solutions, including green chemicals, biodegradable materials, and biofuels, is fueled by environmental concerns and the urgent need for sustainability. However, ethical issues and stringent regulatory frameworks concerning genetic modifications and biosafety present challenges to commercialization and research initiatives. Despite these obstacles, the emergence of advanced therapies and personalized medicine holds significant promise for revolutionizing healthcare and addressing previously untreatable conditions, marking a transformative potential for the industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Synthetic Biology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Synthetic Biology Market Segments Analysis

The global synthetic biology market is segmented by Tool, Application, Technology, and Region. Based on Tool, the market is segmented into Oligonucleotides and Synthetic DNA, Enzymes, Cloning Technologies Kits, Synthetic Cells, Chassis Organisms, and Xeno-Nucleic Acids. Based on Application, the synthetic biology market is segmented into Medical Application, Pharmaceuticals,Drug Discoveryand Therapeutics, Other Medical Application, Artificial Tissue and Tissue Regeneration, Industrial Applications, Other Industries, Food & Agriculture, Environmental Applications. Based on Technology, the market is segmented into Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Site-directed Mutagenesis, Cloning, Measurement and Modelling, Microfluidics, and Nanotechnology. By Region, the synthetic biology market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.

Driver of the Synthetic Biology Market

The synthetic biology market is experiencing significant growth driven by advancements in creating innovative therapies, diagnostics, and vaccines, which are enhancing applications in the healthcare and pharmaceutical industries. Additionally, this technology plays a crucial role in developing genetically engineered crops that possess heightened resistance to diseases and pests, thereby contributing to agricultural productivity and bolstering food security. The combination of these transformative capabilities is fostering an increased demand for synthetic biology solutions, ultimately propelling the overall expansion of this market. As various sectors recognize the potential benefits, the influence of synthetic biology continues to expand across diverse applications.

Restraints in the Synthetic Biology Market

The synthetic biology market faces significant challenges due to the high initial costs associated with developing these technologies, which can limit both scalability and accessibility. Additionally, the complexities involved in engineering, designing, and integrating synthetic biology systems can pose considerable obstacles, undermining the overall reliability and efficiency of these innovations. As companies navigate these hurdles, they may encounter constraints that hinder progress and adoption within the industry. Consequently, the financial burden and technical difficulties associated with synthetic biology could stifle growth and investment in this promising yet intricate field, restricting its potential impact on various sectors.

Market Trends of the Synthetic Biology Market

The Synthetic Biology market is witnessing a significant trend towards innovation in epigenetics technologies, as emerging companies recognize the challenges posed by the complex interplay between gene expression, epigenetics, and DNA sequences. The inconsistencies arising from over-activation of synthetic constructs have highlighted the need for more precise and controlled approaches in genetic engineering. New entrants are developing advanced solutions that enable better manipulation of epigenetic factors, thereby enhancing the reliability and predictability of synthetic biology applications. This focus on overcoming epigenetic challenges is poised to drive advancements in various sectors, including agriculture, healthcare, and industrial biotechnology.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Patent Analysis
Pricing Analysis
Regulatory Analysis
Value Chain Analysis
Ecosystem of the Market
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Synthetic Biology Market by Tool

Market Overview
Oligonucleotides and Synthetic DNA
Enzymes
Cloning Technologies Kits
Synthetic Cells
Chassis Organisms
Xeno-nucleic Acids

Synthetic Biology Market by Technology

Market Overview
Gene Synthesis
Genome Engineering
Sequencing, Bioinformatics
Site-directed Mutagenesis
Cloning
Measurement and Modelling
Microfluidics
Nanotechnology

Synthetic Biology Market by Application

Market Overview

Synthetic Biology Market Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- Italy
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

[if !supportLists] [endif] Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novozymes (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ginkgo Bioworks (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amyris (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Precigen, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Twist Bioscience (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synthetic Genomics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Codexis, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synthego (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Enzymes (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bota Biosciences Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Biogene (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enbiotix, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New England Biolabs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pareto Bio, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments